Pharma Block Sciences (Nanjing) (SZSE:300725) Net Income (Continuing Operations) : ¥206 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Pharma Block Sciences (Nanjing) Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Pharma Block Sciences (Nanjing)'s Net Income (Continuing Operations) for the three months ended in Mar. 2025 was ¥36 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥206 Mil.

Pharma Block Sciences (Nanjing) Net Income (Continuing Operations) Historical Data

The historical data trend for Pharma Block Sciences (Nanjing)'s Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Block Sciences (Nanjing) Net Income (Continuing Operations) Chart

Pharma Block Sciences (Nanjing) Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income (Continuing Operations)

Get a 7-Day Free Trial

184.21

503.77

325.89

197.36

219.54

Pharma Block Sciences (Nanjing) Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income (Continuing Operations)	Get a 7-Day Free Trial															49.49	49.21	33.10	87.75	35.79

Pharma Block Sciences (Nanjing) Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥206 Mil.

Pharma Block Sciences (Nanjing) (SZSE:300725) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Pharma Block Sciences (Nanjing) Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Pharma Block Sciences (Nanjing)'s Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Block Sciences (Nanjing) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharma Block Sciences (Nanjing) Inc (SZSE:300725) » Definitions » Net Income (Continuing Operations)

Traded in Other Exchanges

N/A

Address

10 Xuefu Road, Nanjing High-tech Industrial Development Zone, Jiangsu, Nanjing, 210032, CHN, 210032

Website

http://www.pharmablock.com

Pharma Block Sciences (Nanjing) Inc is a chemistry products and services provider through the pharmaceutical research and development process. Its core business activities include pilot plant and commercial manufacturing of key intermediates and active pharmaceutical ingredient, process development, custom synthesis and building blocks.

Executives

Yang Min Min	Directors, executives
	Directors, executives
Chen La Mei	Executives
Wu Xi Han	Director
	Executives
	Directors, executives
Luo Fei	Supervisors

Pharma Block Sciences (Nanjing) Headlines

No Headlines